Literature DB >> 27364695

Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.

J-P Obeid1, R Stoyanova1, D Kwon2, M Patel1, K Padgett1, J Slingerland3, C Takita1, N Alperin4, M Yepes4, Y H Zeidan5.   

Abstract

PURPOSE: Obesity is associated with adverse outcomes in breast cancer patients. Fat-specific cytokines (adipokines) have been proposed as key drivers of breast cancer progression, invasion, and metastasis. We aimed at assessing correlations between peri-tumoral fat, quantified on magnetic resonance imaging (MRI) and pathologic factors potentially impacting therapy recommendations.
METHODS: We retrospectively reviewed records of 63 patients with early stage breast cancer who underwent preoperative MRI imaging using appropriately weighted series for breast and tumor contouring. Fat volumes were generated through voxel intensity filtering. The peri-tumoral region was defined as the intersection of a 1-cm spherical extension around the tumor and the breast contour. Peri-tumoral fat was defined as the fraction of a fat content in this volume. Surgical pathology records were used to extract clinical data. Statistical analyses were conducted using Pearson and Spearman correlation coefficients.
RESULTS: Among reviewed patients, 45 had T1 tumors (1.22 ± 0.85 cm diameter) and 18 had T2 tumors (2.08 ± 1.06 cm). Axillary lymph nodes were dissected in 31 and positive in 17 patients analyzed. Peri-tumoral fat ratio ranged between 25 and 99 %. Peri-tumoral fat ratio significantly correlated with the nodal-positive ratio of positive axillary lymph nodes (r = 0.532). Peri-tumoral fat ratio demonstrated optimally prominent correlation among obese patients upon body mass index categorical stratification.
CONCLUSIONS: In women with early stage breast cancer, peri-tumoral fat correlates positively with the ratio of pathologically involved axillary nodes. This work highlights a novel method for quantitating peri-tumoral fat content. Preoperative breast MRI may be utilized to predict extent of axillary disease.

Entities:  

Keywords:  Adipose tissue; Breast cancer; MRI; Radiomics

Mesh:

Year:  2016        PMID: 27364695     DOI: 10.1007/s12094-016-1526-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  33 in total

1.  Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies.

Authors:  M Rota; F Rumi; V Bagnardi; L Dal Maso; A Zucchetto; F Levi; C La Vecchia; A Tavani
Journal:  BJOG       Date:  2015-11-06       Impact factor: 6.531

Review 2.  Adipose tissue dysfunction and its effects on tumor metabolism.

Authors:  Jonathan Diedrich; Halina Chkourko Gusky; Izabela Podgorski
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

3.  Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors.

Authors:  T Kuehn; W Klauss; M Darsow; S Regele; F Flock; C Maiterth; R Dahlbender; I Wendt; R Kreienberg
Journal:  Breast Cancer Res Treat       Date:  2000-12       Impact factor: 4.872

Review 4.  Modifiable Lifestyle Factors and Breast Cancer Outcomes: Current Controversies and Research Recommendations.

Authors:  Pamela J Goodwin; Christine B Ambrosone; Chi-Chen Hong
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 5.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

Review 6.  Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.

Authors:  Sajid Khan; Samriddhi Shukla; Sonam Sinha; Syed Musthapa Meeran
Journal:  Cytokine Growth Factor Rev       Date:  2013-10-21       Impact factor: 7.638

Review 7.  Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.

Authors:  Angeles Alvarez Secord; Vic Hasselblad; Vivian E Von Gruenigen; Paola A Gehrig; Susan C Modesitt; Victoria Bae-Jump; Laura J Havrilesky
Journal:  Gynecol Oncol       Date:  2015-10-31       Impact factor: 5.482

8.  Triple-negative breast cancer: correlation between MR imaging and pathologic findings.

Authors:  Takayoshi Uematsu; Masako Kasami; Sachiko Yuen
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

9.  Molecular imaging of breast cancer lymph node metastasis.

Authors:  Narges K Tafreshi; Robert J Gillies; David L Morse
Journal:  Eur J Radiol       Date:  2012-09       Impact factor: 3.528

10.  Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer.

Authors:  S Amor; M C Iglesias-de la Cruz; E Ferrero; O García-Villar; V Barrios; N Fernandez; L Monge; A L García-Villalón; M Granado
Journal:  Int J Colorectal Dis       Date:  2015-10-22       Impact factor: 2.571

View more
  15 in total

Review 1.  "Radio-oncomics" : The potential of radiomics in radiation oncology.

Authors:  Jan Caspar Peeken; Fridtjof Nüsslin; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-07-07       Impact factor: 3.621

2.  Correlation between obesity and fat-infiltrated axillary lymph nodes visualized on mammography.

Authors:  Roberta M diFlorio Alexander; Steffen J Haider; Todd MacKenzie; Martha E Goodrich; Julie Weiss; Tracy Onega
Journal:  Br J Radiol       Date:  2018-01-05       Impact factor: 3.039

Review 3.  Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.

Authors:  Sanjay Saxena; Biswajit Jena; Neha Gupta; Suchismita Das; Deepaneeta Sarmah; Pallab Bhattacharya; Tanmay Nath; Sudip Paul; Mostafa M Fouda; Manudeep Kalra; Luca Saba; Gyan Pareek; Jasjit S Suri
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

4.  Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics.

Authors:  Bin Zhang; Fusheng Ouyang; Dongsheng Gu; Yuhao Dong; Lu Zhang; Xiaokai Mo; Wenhui Huang; Shuixing Zhang
Journal:  Oncotarget       Date:  2017-08-02

Review 5.  The crucial role of multiomic approach in cancer research and clinically relevant outcomes.

Authors:  Miaolong Lu; Xianquan Zhan
Journal:  EPMA J       Date:  2018-02-21       Impact factor: 6.543

Review 6.  Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota?

Authors:  Benedicte F Jordan; Florian Gourgue; Patrice D Cani
Journal:  Curr Pathobiol Rep       Date:  2017-10-24

Review 7.  The role of ectopic adipose tissue: benefit or deleterious overflow?

Authors:  Toon J I De Munck; Peter B Soeters; Ger H Koek
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

8.  Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.

Authors:  Lal Hussain; Pauline Huang; Tony Nguyen; Kashif J Lone; Amjad Ali; Muhammad Salman Khan; Haifang Li; Doug Young Suh; Tim Q Duong
Journal:  Biomed Eng Online       Date:  2021-06-28       Impact factor: 2.819

Review 9.  Radiogenomics in brain, breast, and lung cancer: opportunities and challenges.

Authors:  Apurva Singh; Rhea Chitalia; Despina Kontos
Journal:  J Med Imaging (Bellingham)       Date:  2021-06-18

10.  MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.

Authors:  Vetri Sudar Jayaprakasam; Viktoriya Paroder; Peter Gibbs; Raazi Bajwa; Natalie Gangai; Ramon E Sosa; Iva Petkovska; Jennifer S Golia Pernicka; James Louis Fuqua; David D B Bates; Martin R Weiser; Andrea Cercek; Marc J Gollub
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.